PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights • Neuroendovascular diseases: An overview • Brain aneurysm • Endovascular embolization • Regulatory environment PART 05: Market landscape • Market overview • Five forces analysis PART 06: Market segmentation by product type • Neuroendovascular stents • Access devices • Flow diversion devices • Other neuroendovascular non-coil devices PART 07: Geographical segmentation • Neuroendovascular non-coils market in Americas • Neuroendovascular non-coils market in EMEA • Neuroendovascular non-coils market in APAC PART 08: Market drivers • High incidence rates of brain aneurysm and cerebral disorders • Growing demand for minimally invasive procedures with improved medical imaging • Rise in demand for intracranial stenting procedures • Rise in recognition and awareness PART 09: Impact of drivers PART 10: Market challenges • Shortage of skilled surgeons and technicians • High cost of stenting procedures • Complications associated with neuroendovascular procedures • Manufacturing hurdles and delay in product launch due to stringent regulatory approvals • Lack of adequate clinical evidence PART 11: Impact of drivers and challenges PART 12: Market trends • Increase in market penetration of non-coil devices through new technological advances • Growing surgeons' interests in adoption of flow diversion devices and neurovascular stents • Growing number of ongoing clinical trials • Transforming marketing and sales strategies for neuroendovascular non-coil devices PART 13: Vendor landscape • Competitive scenario • Key news PART 14: Key vendor analysis • DePuy Synthes • Medtronic • MicroVention • Stryker • Other prominent vendors PART 15: Appendix • List of abbreviations PART 16: Explore Technavio   List of Exhibits Exhibit 01: Product offerings Exhibit 02: Neuroendovascular disease segments in 2014 Exhibit 03: Various treatment options available for neuroendovascular diseases Exhibit 04: Neuroendovascular disease: New techniques and technologies Exhibit 05: Comparison of flow diversion and endovascular coiling treatments for intracranial aneurysm based on different parameters Exhibit 06: Series of patients with unruptured aneurysms Exhibit 07: Methods of endovascular embolization for intracranial aneurysm treatment Exhibit 08: Classification of medical devices by FDA Exhibit 09: Snapshot of global neuroendovascular non-coils market Exhibit 10: Snapshot of global neuroendovascular non-coils market Exhibit 11: Global neuroendovascular non-coils market 2015-2020 ($ billions) Exhibit 12: Global neuroendovascular non-coils market analysis: Developed and emerging markets Exhibit 13: Global neuroendovascular non-coils market: Opportunity analysis Exhibit 14: Five forces analysis Exhibit 15: Global neuroendovascular non-coils market segmentation by product type 2015 and 2020 Exhibit 16: Global neuroendovascular non-coils market segmentation by product type 2015 Exhibit 17: Global neuroendovascular non-coils market segmentation by product type: Lifecycle analysis 2015 Exhibit 18: Commonly used ICD-9-CM diagnosis codes Exhibit 19: Global neuroendovascular stents market 2015-2020 ($ millions) Exhibit 20: Global neuroendovascular access devices market 2015-2020 ($ millions) Exhibit 21: Number of flow diversion aneurysm procedures performed in 2013 Exhibit 22: Number of flow diversion aneurysm procedures performed in 2014 Exhibit 23: List of clinical trials for endovascular aneurysm and flow diversion treatment Exhibit 24: Approved indications for flow diverters in US and Europe Exhibit 25: Global neuroendovascular flow diversion devices market 2015-2020 ($ millions) Exhibit 26: Clinical studies that showed positive results for embolic protection devices Exhibit 27: Global other neuroendovascular non-coil devices market 2015-2020 ($ millions) Exhibit 28: Neuroendovascular non-coils market segmentation by product type 2015-2020 ($ millions) Exhibit 29: Neuroendovascular non-coils market segmentation by product type 2015-2020 (%) Exhibit 30: Global neuroendovascular non-coils market segmentation by geography Exhibit 31: Global neuroendovascular non-coils market: Geographical presence Exhibit 32: Global neuroendovascular non-coils market segmentation by geography 2015 Exhibit 33: Global neuroendovascular non-coils market segmentation by geography 2015 Exhibit 34: Neuroendovascular non-coils market in Americas 2015-2020 ($ millions) Exhibit 35: Neuroendovascular non-coils market in EMEA 2015-2020 ($ millions) Exhibit 36: Neuroendovascular non-coils market in APAC 2015-2020 ($ millions) Exhibit 37: Global neuroendovascular non-coils market segmentation by geography 2015-2020 ($ millions) Exhibit 38: Global neuroendovascular non-coils market segmentation by geography 2015-2020 (%) Exhibit 39: Impact of drivers Exhibit 40: Reported cases of rupture at later stage in large aneurysm (17 mm to 35 mm) Exhibit 41: Five force analysis of global neuroendovascular non-coils market Exhibit 42: Impact of drivers and challenges Exhibit 43: Few technological advancements related to neuroendovascular non-coil devices Exhibit 44: Major ongoing clinical trials Exhibit 45: Strategies of large and small neuroendovascular non-coil device manufacturers Exhibit 46: Impacts of trends on global neuroendovascular non-coils market Exhibit 47: Competitive structure analysis of global neuroendovascular non-coils market 2015 Exhibit 48: Market penetration of various manufacturers of neuroendovascular non-coils market 2015 Exhibit 49: Strategic success factors of companies in global neuroendovascular non-coils market Exhibit 50: Presence of vendors in global neuroendovascular non-coils market Exhibit 51: DePuy Synthes profile Exhibit 52: DePuy Synthes strength analysis Exhibit 53: DePuy Synthes growth strategy matrix Exhibit 54: DePuy Synthes: Opportunity assessment Exhibit 55: Medtronic profile Exhibit 56: Medtronic strength analysis Exhibit 57: Medtronic growth strategy matrix Exhibit 58: Medtronic: Opportunity assessment Exhibit 59: MicroVention profile Exhibit 60: MicroVention strength analysis Exhibit 61: MicroVention growth strategy matrix Exhibit 62: MicroVention: Opportunity assessment Exhibit 63: Stryker profile Exhibit 64: Stryker strength analysis Exhibit 65: Stryker growth strategy matrix Exhibit 66: Stryker: Opportunity assessment

DePuy Synthes, Medtronic, MicroVention, Stryker, Abiomed, AdvanSource Biomaterials, AGA Medical, Allium Medical, AngioDynamics, Angioslide, Atrium Medical, Biophan Technologies, Biosense Webster, Cardiac Science, CardiacAssist, Dextera Surgical, Cardio-Flow, Claret Medical, Contego Medical, Cook Group, Cryolife, Innovative Cardiovascular Solutions, Keystone Heart, St. Jude Medical, phenox, InspireMD, Acandis, Transverse Medical.